Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanyan Cui

Showing results (151-160 of 152) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 152 results.
Technology in Cancer Research & Treatment|February 2, 2023
A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for <i>RAS/BRAF</i> Wild-Type Metastatic Colorectal Cancer: A Clinical Trial ProtocolJinjie He, Yue Liu, Chengcheng Liu, et al.
Nano Today|March 24, 2021
Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel coronavirusYaling Wang, Yuping Xie, Jia Luo, et al.
Pageof 16

Showing results (151-160 of 152) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 152 results.
Technology in Cancer Research & Treatment|February 2, 2023
A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for <i>RAS/BRAF</i> Wild-Type Metastatic Colorectal Cancer: A Clinical Trial ProtocolJinjie He, Yue Liu, Chengcheng Liu, et al.
Nano Today|March 24, 2021
Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel coronavirusYaling Wang, Yuping Xie, Jia Luo, et al.
Pageof 16